Microbiome-mitochondria crosstalk in neuro-oncology: molecular mechanisms, immunometabolic reprogramming, and therapeutic opportunities
Open Access
- 21 October 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiomes
- Vol. 5, 1983174
Abstract
Although the gut microbiome is increasingly recognized as an important regulator of metabolic, immune, and neurophysiological functions, and mitochondrial dysfunction is considered a hallmark of metabolic flexibility, oxidative stress, and resistance to therapy in cancers, the role of microbiome-derived cues and mitochondrial processes in brain tumors remains poorly understood. The Microbiome-Gut-Brain-Mitochondria Axis in Neuro-Oncology provides a framework for understanding metabolism and immunity in neuro-oncology by highlighting this axis and emphasizing its role in glioblastoma. Metabolites produced by the microbiome, including short-chain fatty acids, bile acid metabolites, tryptophan metabolites, and other microbial compounds, have been shown to affect the immune system, barrier function, cellular metabolism, and neural signaling. Mitochondria are capable of functioning as intracellular communication mechanisms that will help to decipher those signals in order to create energy, ROS, calcium communication, biogenesis of mitochondria, quality control, and apoptosis. These processes may contribute to metabolic plasticity in glioblastomas, including glycolytic, oxidative phosphorylation, and amino- and lipid-metabolic adaptations, mitochondrial transfer, adaptation to hypoxia, tumor cell stemness, and immune suppression in the tumor microenvironment. The article also discusses the relationships between microbiome-derived cues, mitochondria, and tumor-associated immune populations. Microbiome-derived and mitochondrial biomarkers, combined with multi-omics approaches, single-cell technologies, spatial biology, artificial intelligence, and new experimental models, may help to identify relevant microbiome-mitochondria signatures. Modulating the microbiome, mitochondria, and combination therapies appears promising for glioblastomas. However, the causative link between microbiome-derived mitochondrial mechanisms and human brain tumors remains unproven. The necessity of prospective and mechanistic studies of the microbiome, mitochondria, metabolism, immunity, and clinical aspects arises.Keywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India (DST-SERB (CRG/2018/003780), ANRF (ANRF/ARG/2025/011396/LS))
- Department of Biotechnology, Ministry of Science and Technology, India (DBT-BUILDER (BT/INF/22/SP47619/2022))
This publication has 174 references indexed in Scilit:
- Molecular Dialogues in the Mitochondria–Microbiome Crosstalk: Metabolites, Signaling, and ImmunityComprehensive Physiology, 2026
- Interconnection between gut microbial metabolites and mitochondrial ROS production: implications for cellular healthMolecular and Cellular Biochemistry, 2025
- Genetically Engineered Brain Organoids Recapitulate Spatial and Developmental States of Glioblastoma ProgressionAdvanced Science, 2025
- Microglia and macrophages in glioblastoma: landscapes and treatment directionsMolecular Oncology, 2024
- Recruiting T‐Cells toward the Brain for Enhanced Glioblastoma Immunotherapeutic Efficacy by Co‐Delivery of Cytokines and Immune Checkpoint Antibodies with Macrophage‐Membrane‐Camouflaged NanovesiclesAdvanced Materials, 2023
- Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypesActa Neuropathologica, 2019
- An insight into gut microbiota and its functionalitiesCellular and Molecular Life Sciences, 2018
- Mitochondrial retrograde signaling in the nervous systemFEBS Letters, 2017
- Mitochondrial quality control by the Pink1/Parkin systemCell and tissue research, 2016
- Probiotics, gut microbiota, and their influence on host health and diseaseMolecular Nutrition & Food Research, 2016